fleroxacin has been researched along with Liver Abscess in 1 studies
Fleroxacin: A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.
fleroxacin : A fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-negative bacteria.
Liver Abscess: Solitary or multiple collections of PUS within the liver as a result of infection by bacteria, protozoa, or other agents.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The object of this open-label, randomized, comparative study was to evaluate the efficacy and safety of fleroxacin versus conventional therapy (cefazolin plus gentamicin/cephalexin) in the treatment of patients with bacterial liver abscess." | 9.10 | A pilot study of oral fleroxacin once daily compared with conventional therapy in patients with pyogenic liver abscess. ( Chen, YS; Chen, YW; Huang, WK; Lee, SS; Lin, HH; Liu, YC; Wann, SR; Yen, MY, 2002) |
| "The object of this open-label, randomized, comparative study was to evaluate the efficacy and safety of fleroxacin versus conventional therapy (cefazolin plus gentamicin/cephalexin) in the treatment of patients with bacterial liver abscess." | 5.10 | A pilot study of oral fleroxacin once daily compared with conventional therapy in patients with pyogenic liver abscess. ( Chen, YS; Chen, YW; Huang, WK; Lee, SS; Lin, HH; Liu, YC; Wann, SR; Yen, MY, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YW | 1 |
| Chen, YS | 1 |
| Lee, SS | 1 |
| Yen, MY | 1 |
| Wann, SR | 1 |
| Lin, HH | 1 |
| Huang, WK | 1 |
| Liu, YC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prospective, Randomized, Open-Labeled, Active-Controlled Comparison of Moxifloxacin Versus Ceftriaxone in the Treatment of Primary Pyogenic Liver Abscess: A Pilot Study[NCT00895089] | Phase 4 | 24 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for fleroxacin and Liver Abscess
| Article | Year |
|---|---|
A pilot study of oral fleroxacin once daily compared with conventional therapy in patients with pyogenic liver abscess.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial I | 2002 |